Dihydrolipoamide Branched Chain Transacylase E2 (DBT) Peptid
DBT
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle DBT Produkte
- DBT (Dihydrolipoamide Branched Chain Transacylase E2 (DBT))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- NYVCFFGYPS FKYSHPHHFL KTTAALRGQV VQFKLSDIGE GIREVTVKEW
- Produktmerkmale
- A synthetic peptide for use as a blocking control in assays to test for specificity of DBT antibody, catalog no. 70R-2499
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
- Target
- DBT (Dihydrolipoamide Branched Chain Transacylase E2 (DBT))
- Synonyme
- BCATE2 Peptide, BCKAD-E2 Peptide, BCKADE2 Peptide, E2 Peptide, E2B Peptide, D3Wsu60e Peptide, im:7147214 Peptide, zgc:103768 Peptide, E2b Peptide, dihydrolipoamide branched chain transacylase E2 Peptide, hypothetical protein Peptide, dihydrolipoamide branched chain transacylase E2 L homeolog Peptide, DBT Peptide, dbt Peptide, CpipJ_CPIJ006326 Peptide, BDBG_05874 Peptide, NAEGRDRAFT_78509 Peptide, VDBG_04820 Peptide, PGTG_17722 Peptide, Dbt Peptide, dbt.L Peptide
- Substanzklasse
- Viral Protein
-
Sie sind hier:
